The newsletters offer you the access to the latest information regarding HeartLogic™ Heart Failure Diagnostic as well as to a set of patient cases.
Newsletter 10/2021
In this issue, we describe in detail the last findings on the performances of HeartLogic in clinical practice from the RE-HEART registry.
Newsletter 9/2021
In this issue, we analyse an HeartLogic analysis for the Management of Heart Failure (MANAGE-HF) study: a trial designed to evaluate the clinical efficacy and usefulness of HeartLogic.
Newsletter 8/2021
In this issue, we analyse a new interesting analysis on HeartLogic which has been recently published on Circulation Heart Failure Journal.
Newsletter 7/2021
In this issue, we would like to share with you the new clinical evidence on HeartLogic through 3 abstract presentations and 1 ePoster.
Newsletter 6/2021
In this issue, we are pleased to present you a recent publication from the DASAP-HF Study (The Diagnosis of Sleep Apnea in Patient With Heart Failure Study) about the correlation between cardiovascular events and the Respiratory Disturbance Index (RDI) computed by the ApneaScan™ algorithm.
Newsletter 5/2021
In this issue we are pleased to share with you content about HeartLogic presented during the European Heart Rhythm Association (EHRA) Congress - which took place few weeks ago: a live presentation and two posters.
Newsletter 4/2021
In this issue, we analyse a review of the most important publications about HeartLogic algorithm which has been published on Sensors Journal by Dr. Feijen at al. from the University Medical Center of Leiden (Netherlands).
Newsletter 3/2021
In this issue, we analyse a new evidence from the MultiSENSE study which has been recently published by Dr. Gardner on ESC Heart Failure Journal.
Newsletter 2/2021
In this issue, we analyse a case series on the performance of HeartLogic in Covid-19 patients and a review about a suggested strategy to manage heart failure patients during a time of social distancing, in order to optimize the ambulatory accesses.
Newsletter 1/2021
In this first issue of 2021, we analyse a publication on the performance of HearLogic in a COVID-19 patient and an abstract presented at the American Heart Association.